CL264
目录号 : GC39361
CL264 是一种有效且高度特异性的 Toll 样受体 7 (TLR7) 配体。
Cas No.:1510712-69-2
Sample solution is provided at 25 µL, 10mM.
CL264 is a a potent and highly specific toll-like receptor 7 (TLR7) ligand. Immune cells utilize toll-like receptors (TLRs) to sense pathogen associated molecular patterns (PAMPs), which represents the starting point of the innate immune response s[1].
Using concentrations from 0.5 to 10?μg/mL, stimulation with CL264 resulted in a dose-dependent secretion of TNF-α?after 6 hours. CAL-1 cells were stimulated with CL264 (5?μg/mL) for up to 12 hours. ?CAL-1 cells were seeded into 96-well plates. After overnight resting, cells were stimulated with CL264 or 9.2s RNA or the combination of both. After incubation as indicated, cell supernatant was analyzed for TNF-α, IL-6, and IFN-β?by ELISA. CL264 led to a robust, time-dependent release of TNF-α?reaching absolute levels of 1347?pg/mL TNF-α?into the supernatant[1].Peripheral blood mononuclear cells (PBMCs) stimulated with CL264, IL-6, IL-8 and IL-12 were significantly stimulated[2].
The TLR7 agonist CL264 ,40 μg/injectionat day 0, 3 and 6 after tumor grafting, stimulated tumor growth, and this pro-tumorigenic effect was completely lost in the absence of MDSCs, both in WT mice and in TLR7 KO mice. The tumor growth exacerbating effect of TLR7 stimulation is mediated by the increased number of MDSCs within the tumor microenvironment.The secretion of CCL2 and GM-CSF by tumor cells was confirmed in vitro, which was found increased in supernatants of CL264-stimulated cells,these results suggest that CL264 may stimulate the recruitment of MDSCs via the induction of CCL2 and GM-CSF.[3].
References:
[1].Hilbert T, Steinhagen F, et al. Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1. Mediators Inflamm. 2015;2015:948540.
[2].Dajon M, Iribarren K, et al. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 2018 Oct 11;8(1):e1505174.
CL264 是一种有效且高度特异性的 Toll 样受体 7 (TLR7) 配体。免疫细胞利用 Toll 样受体 (TLR) 感知病原体相关分子模式 (PAMP),这是先天免疫反应的起点 s[1]。
使用 0.5 至 10μg/mL 的浓度,用 CL264 刺激会在 6 小时后导致 TNF-α 的剂量依赖性分泌。用 CL264 (5μg/mL) 刺激 CAL-1 细胞长达 12 小时。将 CAL-1 细胞接种到 96 孔板中。过夜休息后,用 CL264 或 9.2s RNA 或两者的组合刺激细胞。如所示孵育后,通过 ELISA 分析细胞上清液中的 TNF-α、IL-6 和 IFN-β。 CL264 导致上清液中 TNF-α 的稳健、时间依赖性释放达到 1347pg/mL TNF-α 的绝对水平[1]。用 CL264 刺激的外周血单核细胞 (PBMC), IL-6、IL-8和IL-12均得到显着刺激[2]。
TLR7 激动剂 CL264,40 μg/ 次注射,在肿瘤移植后的第 0、3 和 6 天,刺激肿瘤生长,并且在没有 MDSCs 的情况下,这种促肿瘤发生作用在 WT 小鼠和 TLR7 KO 小鼠中完全消失. TLR7 刺激的肿瘤生长加剧作用是由肿瘤微环境中 MDSC 数量的增加介导的。体外证实了肿瘤细胞分泌 CCL2 和 GM-CSF,这在 CL264 刺激细胞的上清液中发现增加,这些结果表明,CL264 可能通过诱导 CCL2 和 GM-CSF 刺激 MDSCs 的募集。[3]。
Cell experiment [1]: | |
Cell lines |
Lewis lung carcinoma (LLC),Bone marrow derived macrophages(BMSMs) |
Preparation Method |
Macrophages were cultivated in the presence or absence of CL264 for 24 h, before tumor cells were added and co-cultured for 42 h. Radiolabeled thymidine was used to detect tumor cell growth and was added to the co-cultures 18 h before cell harvest. |
Reaction Conditions |
Macrophages,CL264(40ng/ml),LLC co-cultured for 42 h |
Applications |
CL264 stimulating the BMDMs and it resulted in inhibition of LLC cells, but only when it was used together with IFN-γ. |
Animal experiment [2]: | |
Animal models |
ild-type C57Bl/6J mice,TLR7 Knock out C57Bl/6J mice |
Preparation Method |
Cancer cells - Murine lung adenocarcinoma LLC-luc cells (1E6 in 100μl PBS/injection) were injected into the flank of recipient mice. Mice then received intra-tumor injections of CL264 at day 0, 3 and 6 after tumor grafting. |
Dosage form |
40μg/injection, intra-tumor injection |
Applications |
Intratumoral injection of the TLR7 agonist CL264 induced a pro-tumorigenic effect.CL264 in TLR7 KO mice, similar to that observed in WT mice.These results clearly demonstrate that the pro-tumorigenic effect of CL264 effect is mediated by an effect on TLR7 expressed by malignant (rather than immune) cells. |
References: [1]. Müller E, Christopoulos PF, et al. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages. Front Immunol. 2017 Oct 26;8:1383. [2]. Dajon M, Iribarren K, et al. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 2018 Oct 11;8(1):e1505174. |
Cas No. | 1510712-69-2 | SDF | |
Canonical SMILES | O=C(O)CNC(C1=CC=C(CN2C(NC3=C(N)N=C(NCCCC)N=C23)=O)C=C1)=O | ||
分子式 | C19H23N7O4 | 分子量 | 413.43 |
溶解度 | DMSO : 25 mg/mL (60.47 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 2.4188 mL | 12.0939 mL | 24.1879 mL |
5 mM | 0.4838 mL | 2.4188 mL | 4.8376 mL |
10 mM | 0.2419 mL | 1.2094 mL | 2.4188 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet